Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 423

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Open access
Perrot, Ivan, Michaud, Henri-Alexandre, Giraudon-Paoli, Marc, Augier, Séverine, Docquier, Aurélie, Gros, Laurent, Courtois, Rachel, Déjou, Cécile, Jecko, Diana, Becquart, Ondine, Rispaud-Blanc, Hélène, Gauthier, Laurent, Rossi, Benjamin, Chanteux, Stéphanie, Gourdin, Nicolas, Amigues, Beatrice, Roussel, Alain, Bensussan, Armand, Eliaou, Jean-François, Bastid, Jérémy, Romagné, François, Morel, Yannis, Narni-Mancinelli, Emilie, Vivier, Eric, Paturel, Carine, Bonnefoy, Nathalie·2019·Cell Reports
DOI 10.1016/j.celrep.2019.04.091
Open this paper in CoChat — free account

Abstract

Immune checkpoint inhibitors have revolutionized cancer treatment. However, many cancers are resistant to ICIs, and the targeting of additional inhibitory signals is crucial for limiting tumor evasion. The production of adenosine via the sequential activity of CD39 and CD73 ectoenzymes participates to the generation of an immunosuppressive tumor microenvironment. In order to disrupt the adenosine pathway, we generated two antibodies, IPH5201 and IPH5301, targeting human membrane-associated and soluble forms of CD39 and CD73, respectively, and efficiently blocking the hydrolysis of immunogenic ATP into immunosuppressive adenosine. These antibodies promoted antitumor immunity by stimulating dendritic cells and macrophages and by restoring the activation of T cells isolated from cancer patients. In a human CD39 knockin mouse preclinical model, IPH5201 increased the anti-tumor activity of the ATP-inducing chemotherapeutic drug oxaliplatin. These results support the use of anti-CD39 and anti-CD73 monoclonal antibodies and their combination with immune checkpoint inhibitors and chemotherapies in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.04.091

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 423

Metadata

Authors
Perrot, I., Michaud, H.-A., Giraudon-Paoli, M., Augier, S., Docquier, A., Gros, L., Courtois, R., Déjou, C., Jecko, D., Becquart, O., Rispaud-Blanc, H., Gauthier, L., Rossi, B., Chanteux, S., Gourdin, N., Amigues, B., Roussel, A., Bensussan, A., Eliaou, J.-F., Bastid, J., Romagné, F., Morel, Y., Narni-Mancinelli, E., Vivier, E., Paturel, C., & Bonnefoy, N.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-05
Volume
27
Issue
8
Pages
2411-2425.e9
ISSN
2211-1247 (ISSN-L)
DOI
10.1016/j.celrep.2019.04.091
OpenAlex
W2945715301
Cited by
423
References
51
FWCI
33.06
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.